The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.
PIMCO RAFI Dyn Multi-Factor Intl Eq ETF MFDX
Morningstar’s Analysis MFDX
Will MFDX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 9.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 1.35 | 3.8 Mil | Healthcare |
Unilever PLC | 1.17 | 3.3 Mil | Consumer Defensive |
Offset: Cash | 1.11 | 3.1 Mil | Cash and Equivalents |
SAP SE | 0.95 | 2.7 Mil | Technology |
AstraZeneca PLC | 0.89 | 2.5 Mil | Healthcare |
Roche Holding AG | 0.85 | 2.4 Mil | — |
Hitachi Ltd | 0.85 | 2.4 Mil | Industrials |
ASML Holding NV | 0.85 | 2.4 Mil | Technology |
Nestle SA | 0.77 | 2.2 Mil | Consumer Defensive |
Zurich Insurance Group AG | 0.71 | 2.0 Mil | Financial Services |